News 4|1|04

      home

      about us

      management

      board

      r & d

        pipeline

      EC Mechanism
      video
      news
      articles

      patents

      quarterly reports

      contact us

 
 


Click here for animation

 

  <  news & articles  >:

Cell>Point completes clinical pilot study on 99mTc-EC-Annexin V — 4|1|04

HOUSTON,Texas-April1,2004 -Cell>Point L.L.C. completes clinical pilot study on 99mTc-EC-Annexin V at The University of Texas M.D. Anderson Cancer Center. The study evaluated the use of  99m Tc-EC-Annexin V to assess tumor apoptosis (programmed cell death) in patients with primary breast cancer and to detect and image treatment related apoptosis in patients with primary breast cancer. The images produced in the study  exceeded the companyÂ’s expectations. By using 99mTc-EC-Annexin V, the oncologist will be able to detect cell death much more quickly than current practice.

 

© copyright 2001-2007|Cell>Point L.L.C | all rights reserved | maintained by Link2City.com  

Terry Colip 

Home | About Us | Management Team | Scientific Advisory Board | Corporate fact Sheet
EC Mechanism of Action | Video |  R & D | Agents Pipeline | News | Articles | Patents | Corp Financials | Contact Us